Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | Chief Executive Officer, Director | $24.7 M | -$10.1 M | -29.1% | Apr 15, 2024 |
BDTX | Black Diamond Therapeutics, Inc. | Director | Jun 6, 2024 | |||
CNTA | Centessa Pharmaceuticals plc | Director | Jun 25, 2024 | |||
RPTX | Repare Therapeutics Inc. | Director | Jun 17, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|